Compare BioNano Genomics Inc (BNGO) vs Sezzle Inc (SEZL) Price & Performance

Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.

BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.

SEZL trades at $160.25, down 10.66% over the last session, but maintains a bullish technical outlook with support at $156 and resistance at $165. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.43, and raised full-year guidance. Revenue growth accelerated to 29% year-over-year, with net income margin expanding to 30.83%.

Outlook remains positive given consistent earnings beats and product expansion, though high valuation multiples (P/E 43.68) and a recent securities law investigation pose risks. Analyst consensus is split evenly between Buy and Hold, with a $162 price target suggesting modest upside from current levels.